Remdesivir against COVID-19 and Other Viral Diseases

Patients and physicians worldwide are facing tremendous health care hazards that are caused by the ongoing severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) pandemic. Remdesivir (GS-5734) is the first approved treatment for severe coronavirus disease 2019 (COVID-19). It is a nove...

Descripción completa

Detalles Bibliográficos
Autores principales: Malin, Jakob J., Suárez, Isabelle, Priesner, Vanessa, Fätkenheuer, Gerd, Rybniker, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566896/
https://www.ncbi.nlm.nih.gov/pubmed/33055231
http://dx.doi.org/10.1128/CMR.00162-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566896/
https://www.ncbi.nlm.nih.gov/pubmed/33055231
http://dx.doi.org/10.1128/CMR.00162-20

Ejemplares similares